Search - tctmd.com

Displaying 61 - 80 of 767

Sort: Relevancy | Date

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Presenter: Ulf Teichgräber

October 29, 2024

Presentation TCT 2024

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Bernardo Cortese

October 29, 2024

Presentation TCT 2024

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

Presenter: Paulo Caramori

October 29, 2024

Presentation TCT 2024

TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry

Presenter: Aayush Singal

October 29, 2024

Presentation TCT 2024

TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

Presenter: Shoichi Kuramitsu

October 29, 2024

Presentation TCT 2024

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Presenter: Lei Song

October 29, 2024

Presentation TCT 2024

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

Presenter: Matthias Lutz

October 29, 2024

Presentation TCT 2024

TCT 1292: Recurrent Very Late Stent Thrombosis Due to Multiple Interstruts Hollows After First-Generation Sirolimus-Eluting Stent Implantation

Presenter: Takayuki Ishihara

October 29, 2024

Presentation TCT 2024

TCT 455: Quantitative Coronary Dissection Volume After Sirolimus or Paclitaxel Coated Balloon and Lumen Changes at 6 Months: Serial OCT Sub-study of TRANSFORM-I Trial

Presenter: Akihiro Tobe

October 29, 2024

Presentation TCT 2024

TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures

Presenter: Simon Eccleshall

October 29, 2024

Presentation TCT 2024

TCT 44: Angiographic and Clinical Impact of Balloon Inflation Time in Percutaneous Coronary Interventions With Sirolimus-Coated Balloon: A Subanalysis of the EASTBOURNE Study

Presenter: Filippo Luca Gurgoglione

October 28, 2024

Presentation TCT 2024

TCT 41: Paclitaxel-Coated Versus Sirolimus-Coated Balloon Angioplasty for Coronary Artery Disease: A Systematic Review and Meta-Analysis

Presenter: Doosup Shin

October 28, 2024

Presentation TCT 2024

TCT 40: Sirolimus- vs. Paclitaxel-Coated Balloons for Treatment of Coronary Artery Disease

Presenter: Pier Pasquale Leone

October 28, 2024

Presentation TCT 2024

TCT 42: Sirolimus Eluting Balloon for Coronary Intervention: An All-Comers Registry

Presenter: Marco Ferrone

October 28, 2024

Presentation TCT 2024

TCT 434: Clinical Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Kiril Karamfiloff

October 28, 2024

Presentation TCT 2024

TCT 421: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in U.S. Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW-VII Trial

Presenter: David Kandzari

October 28, 2024

Presentation TCT 2024

A Randomized Comparison Between Selution SLR™ Sirolimus-Eluting Balloon and Plain Old Balloon Angioplasty in Patients With Distal Internal Pudendal-Penile Artery Disease and Erectile Dysfunction: The PERFECT-SELUTION First-in-Man Study

Presenter: Tzung-Dau Wang

October 28, 2024

Presentation TCT 2024

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Kiril Karamfiloff

October 28, 2024

Advertisement

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry

TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

TCT 1292: Recurrent Very Late Stent Thrombosis Due to Multiple Interstruts Hollows After First-Generation Sirolimus-Eluting Stent Implantation

TCT 455: Quantitative Coronary Dissection Volume After Sirolimus or Paclitaxel Coated Balloon and Lumen Changes at 6 Months: Serial OCT Sub-study of TRANSFORM-I Trial

TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures

TCT 44: Angiographic and Clinical Impact of Balloon Inflation Time in Percutaneous Coronary Interventions With Sirolimus-Coated Balloon: A Subanalysis of the EASTBOURNE Study

TCT 41: Paclitaxel-Coated Versus Sirolimus-Coated Balloon Angioplasty for Coronary Artery Disease: A Systematic Review and Meta-Analysis

TCT 40: Sirolimus- vs. Paclitaxel-Coated Balloons for Treatment of Coronary Artery Disease

TCT 42: Sirolimus Eluting Balloon for Coronary Intervention: An All-Comers Registry

TCT 434: Clinical Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

TCT 421: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in U.S. Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW-VII Trial

A Randomized Comparison Between Selution SLR™ Sirolimus-Eluting Balloon and Plain Old Balloon Angioplasty in Patients With Distal Internal Pudendal-Penile Artery Disease and Erectile Dysfunction: The PERFECT-SELUTION First-in-Man Study

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content